Cardiovascular disease biotech company Scribe (SCTX.US) sets IPO price at $13-15 per share, aiming to raise $100 millions
智通财经2026/07/21 07:31Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Zhitong Finance APP has learned that Scribe Therapeutics, a biotechnology company dedicated to developing CRISPR gene therapies for high cholesterol and currently in Phase I clinical trials, announced its initial public offering (IPO) terms on Monday. The company plans to issue 7.2 million shares at a price range of $13 to $15 per share, raising $100 million. The company intends to list on the Nasdaq under the stock code "SCTX."
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Crypto prices
MoreBitcoin
BTC
$62,980.29
+0.64%
Ethereum
ETH
$1,882.35
+0.90%
Tether USDt
USDT
$0.9989
+0.00%
USDC
USDC
$0.9999
+0.01%
XRP
XRP
$1
-0.12%
Solana
SOL
$75.44
+0.27%
TRON
TRX
$0.3308
-0.50%
Hyperliquid
HYPE
$56.31
+1.33%
Dogecoin
DOGE
$0.06999
+0.79%
Zcash
ZEC
$488.8
+1.11%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now